Search

everythinglearnresearchcommunity

for

Search:↓

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

More inflammation leads to faster and worse hair loss in women with frontal fibrosing alopecia.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The surgery effectively promoted and maintained weight loss in obese women during the first year.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

The combination of zinc sulfate and calcium pantothenate effectively controls early-stage hair loss.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Low serum ferritin levels are linked to hair loss in women.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.

Hair transplantation has improved to look more natural, but managing patient expectations and using precise techniques are key for the best outcomes.